Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 29, 16:00
2694.95
-7.15 (-0.26%)
VOLUME 690
LIVE
NSE
Mar 29, 15:56
2696.25
-10.05 (-0.37%)
VOLUME 15,020
News on GlaxoSmithKline Pharmaceuticals
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
CCI approves Corona Remedies-GlaxoSmithKline deal

9.56 pm | 07 Mar 2017 |  Source: PTI

Dilo-BM, Dilo-DX, Stelbid and Vitneurin brands of GlaxoSmithKline would be acquired by Corona Remedies along with trademark and goodwill....

Sell GlaxoSmithKline Pharma; target of Rs 1340: Centrum

1.25 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Centrum is bearish on GlaxoSmithKline Pharma has recommended sell rating on the stock with a target price of Rs 1340 in its research report dated Febr...

Stocks in news: Idea, Axis, HUL, McNally, Havells, Mangalam Drug 

8.26 am | 20 Feb 2017 |  Source: CNBC-TV18

Idea Cellular | Axis Bank | Kotak Mahindra Bank | Hindustan Unilever | McNally Bharat | Havells | BPCL | GPT Infra | Mangalam Drugs and GSK Pharma are...

Hold Glaxosmithkline; target of Rs 5773: Edelweiss

11.28 am | 16 Feb 2017 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Glaxosmithkline with a target price of Rs 5773 in its research report dated February 13, 2017....

GlaxoSmithKline Pharma Q3 profit dips 33% to Rs 53 cr

4.58 pm | 11 Feb 2017 |  Source: PTI

The company said mandatory price reductions experienced in the earlier quarters of the year had adversely impacted growth by 5 percent in the current ...

Accumulate GSK Consumer; target of Rs 5988: Prabhudas Lilladher

7.06 pm | 17 Nov 2016 |  Source: Moneycontrol.com

Prabhudas Lilladher has recommended accumulate rating on GSK Consumer with a target price of Rs 5988 in its research report dated November 08, 2016....

Buy GSK Consumer; target of Rs 6765: ICICI Direct

11.42 am | 17 Nov 2016 |  Source: Moneycontrol.com

ICICI Direct is bullish on GSK Consumer has recommended buy rating on the stock with a target price of Rs 6765 in its research report dated November 0...

Hold GSK Consumer; target of Rs 6342: Edelweiss

3.16 pm | 16 Nov 2016 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on GSK Consumer with a target price of Rs 6342 in its research report dated November 08, 2016....

Margins recovering; expect them to normalise around 20%: GSK 

12.38 pm | 28 Oct 2016 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Andrew Aristidou, CFO of GlaxoSmithKline Pharmaceuticals spoke about the results and his outlook for the company. ...

GSK Pharma Q2 net up 3% at Rs 99 cr

2.58 pm | 27 Oct 2016 |  Source: PTI

It had posted net profit of Rs 95.55 crore for the July- September period of the previous fiscal, GSK Pharma said in a BSE filing....

1 2
Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.